287 related articles for article (PubMed ID: 35953100)
1. Living without eosinophils: evidence from mouse and man.
Jackson DJ; Pavord ID
Eur Respir J; 2023 Jan; 61(1):. PubMed ID: 35953100
[TBL] [Abstract][Full Text] [Related]
2. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
Wechsler ME; Klion AD; Paggiaro P; Nair P; Staumont-Salle D; Radwan A; Johnson RR; Kapoor U; Khokhar FA; Daizadeh N; Chen Z; Laws E; Ortiz B; Jacob-Nara JA; Mannent LP; Rowe PJ; Deniz Y
J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2695-2709. PubMed ID: 35636689
[TBL] [Abstract][Full Text] [Related]
3. Eosinophils and eosinophilic immune dysfunction in health and disease.
Jackson DJ; Akuthota P; Roufosse F
Eur Respir Rev; 2022 Mar; 31(163):. PubMed ID: 35082127
[TBL] [Abstract][Full Text] [Related]
4. Adult-onset eosinophilic airway diseases.
Asano K; Ueki S; Tamari M; Imoto Y; Fujieda S; Taniguchi M
Allergy; 2020 Dec; 75(12):3087-3099. PubMed ID: 33040364
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil infiltrates and eosinophil aggregates in chronic rhinosinusitis with nasal polyps and EGPA.
Contro G; Brescia G; Alessandrini L; Barion U; Padoan R; Frigo AC; Schiavon F; Marioni G
Clin Rheumatol; 2021 May; 40(5):1949-1957. PubMed ID: 33094393
[TBL] [Abstract][Full Text] [Related]
6. Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.
Frątczak A; Polak K; Miziołek B; Bergler-Czop B
Acta Dermatovenerol Croat; 2022 Sep; 30(2):116-118. PubMed ID: 36254546
[TBL] [Abstract][Full Text] [Related]
7. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis.
Nagase H; Ueki S; Fujieda S
Allergol Int; 2020 Apr; 69(2):178-186. PubMed ID: 32139163
[TBL] [Abstract][Full Text] [Related]
8. Nasal polyps in eosinophilic granulomatosis with polyangiitis: Structured histopathology and CD105 expression.
Brescia G; Padoan R; Schiavon F; Contro G; Parrino D; Tealdo G; Felicetti M; Frigo AC; Alessandrini L; Marioni G
Am J Otolaryngol; 2020; 41(6):102661. PubMed ID: 32810787
[TBL] [Abstract][Full Text] [Related]
9. Focus on the Involvement of the Nose and Paranasal Sinuses in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Nasal Cytology Reveals Infiltration of Eosinophils as a Very Common Feature.
Seccia V; Baldini C; Latorre M; Gelardi M; Dallan I; Cristofani-Mencacci L; Sellari-Franceschini S; Bartoli ML; Bacci E; Paggiaro P
Int Arch Allergy Immunol; 2018; 175(1-2):61-69. PubMed ID: 29393242
[TBL] [Abstract][Full Text] [Related]
10. Eosinophilic Granulomatosis with Polyangiitis: Clinical Pathology Conference and Review.
Wu EY; Hernandez ML; Jennette JC; Falk RJ
J Allergy Clin Immunol Pract; 2018; 6(5):1496-1504. PubMed ID: 30197069
[TBL] [Abstract][Full Text] [Related]
11. Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia.
Yılmaz I; Bahçecioğlu SN; Türk M; Tutar N; Oymak FS; Gülmez İ
J Asthma; 2019 Feb; 56(2):111-117. PubMed ID: 29611776
[TBL] [Abstract][Full Text] [Related]
12. From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases.
Pavord ID; Bel EH; Bourdin A; Chan R; Han JK; Keene ON; Liu MC; Martin N; Papi A; Roufosse F; Steinfeld J; Wechsler ME; Yancey SW
Allergy; 2022 Mar; 77(3):778-797. PubMed ID: 34402066
[TBL] [Abstract][Full Text] [Related]
13. Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond.
Folci M; Ramponi G; Arcari I; Zumbo A; Brunetta E
Adv Exp Med Biol; 2021; 1347():197-219. PubMed ID: 34031864
[TBL] [Abstract][Full Text] [Related]
14. Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence.
Caminati M; Micheletto C; Norelli F; Olivieri B; Ottaviano G; Padoan R; Piacentini G; Schiappoli M; Senna G; Menzella F
Expert Opin Biol Ther; 2024; 24(1-2):15-23. PubMed ID: 38197326
[TBL] [Abstract][Full Text] [Related]
15. Molecular and cellular staging for the severity of chronic rhinosinusitis.
Kountakis SE; Arango P; Bradley D; Wade ZK; Borish L
Laryngoscope; 2004 Nov; 114(11):1895-905. PubMed ID: 15510011
[TBL] [Abstract][Full Text] [Related]
16. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) presenting as diffuse myositis.
Parent ME; Larue S; Ellezam B
BMC Musculoskelet Disord; 2014 Nov; 15():388. PubMed ID: 25414144
[TBL] [Abstract][Full Text] [Related]
17. [Vasculitides and eosinophilic pulmonary diseases].
Kroegel C; Foerster M; Quickert S; Slevogt H; Neumann T
Z Rheumatol; 2018 Dec; 77(10):907-922. PubMed ID: 30367242
[TBL] [Abstract][Full Text] [Related]
18. Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis.
Yamada T; Miyabe Y; Ueki S; Fujieda S; Tokunaga T; Sakashita M; Kato Y; Ninomiya T; Kawasaki Y; Suzuki S; Saito H
Front Immunol; 2019; 10():74. PubMed ID: 30778348
[No Abstract] [Full Text] [Related]
19. Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases.
Del Pozo V; Bobolea I; Rial MJ; Espigol-Frigolé G; Solans Laqué R; Hernández-Rivas JM; Mora E; Crespo-Lessmann A; Izquierdo Alonso JL; Domínguez Sosa MS; Maza-Solano J; Atienza-Mateo B; Bañas-Conejero D; Moure AL; Rúa-Figueroa Í
Front Immunol; 2023; 14():1310211. PubMed ID: 38250075
[TBL] [Abstract][Full Text] [Related]
20. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]